The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Ratain, Mark J.
One or more keywords matched the following items that are connected to Ratain, Mark J.
Item TypeName
Academic Article Vascular endothelial growth factor pathway.
Academic Article A phase I study of sirolimus and bevacizumab in patients with advanced malignancies.
Academic Article Unsupported off-label chemotherapy in metastatic colon cancer.
Academic Article Phase I dose-escalation study of onartuzumab as a single agent and in combination with bevacizumab in patients with advanced solid malignancies.
Academic Article Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance).
Academic Article Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.
Academic Article Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance).
Academic Article The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation.
Academic Article Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance).
Academic Article Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.
Academic Article Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Academic Article Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Concept Bevacizumab
Academic Article Combining atezolizumab 1200 mg with bevacizumab 15 mg/kg: based on science or just revenues?
Academic Article Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance).
Search Criteria
  • Bevacizumab